For treatment of: nootropic for improving brain function and blood circulation.Fezam nootropics
- For the treatment of internal organs: nervous system, brain
- Appointment: intoxication, memory improvement, asthenic state, emotional disorders, Meniere's disease and syndrome, treatment and prevention of cerebral circulation disorders
- Indications for use:
— insufficiency of cerebral circulation (atherosclerosis of brain vessels, recovery period of ischemic and hemorrhagic strokes, after traumatic brain injuries, encephalopathy of various Genesis);
— diseases of the Central nervous system, accompanied by a decrease in intellectual and mnestic functions (memory, attention, mood disorders);
— conditions after a traumatic brain injury;
— psychoorganic syndrome with a predominance of symptoms of asthenia and adynamia;
— asthenic syndrome of psychogenic origin;
— labyrinthopathies (dizziness, tinnitus, nausea, vomiting, nystagmus);
— Meniere's syndrome;
— prevention of kinetosis;
— prevention of migraine;
— as part of complex therapy for low learning ability in children with psychoorganic syndrome.
— severe renal failure (CC< 20 ml/min);
— severe liver failure;
— psychomotor agitation at the time of drug administration;
— lactation period (breast-feeding);
— children under 5 years of age;
— hypersensitivity to the components of the drug.
With caution, the drug should be prescribed for Parkinson's disease, liver and/or kidney function disorders, hemostasis disorders, and severe bleeding.
Active substance: piracetam – 400 mg, Cinnarizine – 25 mg
Excipients: lactose monohydrate – 55 mg, colloidal silicon dioxide – 15 mg, magnesium stearate – 5 mg
- Manufacturer: Balkanpharma